T1	Disorder 10 41	Malignant mixed mullerian tumor
N1 	Reference T1 UMLS:C0206627	Malignant mixed mullerian tumor
T2	Pharmacological_substance 76 86	raloxifene
N1000 	Reference T2 MeSH:D020849	raloxifene
T3	Disorder 101 141	Uterine malignant mixed mesodermal tumor
T4	Disorder 163 177	uterine cancer
N2 	Reference T4 UMLS:C0153567	uterine cancer
T5	Pharmacological_substance 197 206	tamoxifen
N1001 	Reference T5 MeSH:D013629	tamoxifen
T6	Disorder 278 310	malignant mixed mesodermal tumor
N3 	Reference T6 UMLS:C1334603	malignant mixed mesodermal tumor
T7	Pharmacological_substance 346 356	raloxifene
N1002 	Reference T7 MeSH:D020849	raloxifene
T10	Disorder 421 453	malignant mixed mesodermal tumor
N4 	Reference T10 UMLS:C1334603	malignant mixed mesodermal tumor
T11	Pharmacological_substance 537 547	raloxifene
N1003 	Reference T11 MeSH:D020849	raloxifene
T12	Disorder 552 564	osteoporosis
N5 	Reference T12 UMLS:C0029456	osteoporosis
T13	Pharmacological_substance 701 711	raloxifene
N1004 	Reference T13 MeSH:D020849	raloxifene
T14	Disorder 735 767	malignant mixed mesodermal tumor
N6 	Reference T14 UMLS:C1334603	malignant mixed mesodermal tumor
T15	Disorder 861 884	mullerian abnormalities
T20	Subject 471 490	a 64-year-old woman
T21	Disorder 498 515	bicornuate uterus
N7 	Reference T21 UMLS:C0266387	bicornuate uterus
T22	Speculation_cue 671 674	may
T29	Speculation_cue 184 191	suggest
T30	Subject 847 855	patients
T31	Subject 260 267	a women
